Zions Bancorporation National Association UT Invests $1.34 Million in Hawkins, Inc. $HWKN

Zions Bancorporation National Association UT purchased a new stake in Hawkins, Inc. (NASDAQ:HWKN) in the third quarter, Holdings Channel reports. The institutional investor purchased 7,309 shares of the specialty chemicals company’s stock, valued at approximately $1,336,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. grew its holdings in shares of Hawkins by 2.8% during the third quarter. Vanguard Group Inc. now owns 1,504,831 shares of the specialty chemicals company’s stock worth $274,963,000 after purchasing an additional 41,652 shares during the last quarter. Geode Capital Management LLC boosted its position in Hawkins by 1.1% during the 2nd quarter. Geode Capital Management LLC now owns 478,348 shares of the specialty chemicals company’s stock worth $67,981,000 after buying an additional 5,110 shares during the period. Invesco Ltd. grew its holdings in Hawkins by 50.3% during the 2nd quarter. Invesco Ltd. now owns 282,349 shares of the specialty chemicals company’s stock worth $40,122,000 after acquiring an additional 94,503 shares during the last quarter. Schroder Investment Management Group increased its position in Hawkins by 130.7% in the 2nd quarter. Schroder Investment Management Group now owns 149,397 shares of the specialty chemicals company’s stock valued at $21,229,000 after acquiring an additional 84,651 shares during the period. Finally, Bank of New York Mellon Corp increased its position in Hawkins by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 148,173 shares of the specialty chemicals company’s stock valued at $21,055,000 after acquiring an additional 558 shares during the period. Institutional investors and hedge funds own 69.71% of the company’s stock.

Insiders Place Their Bets

In other news, Director James A. Faulconbridge purchased 1,500 shares of the business’s stock in a transaction on Wednesday, February 4th. The shares were acquired at an average price of $129.29 per share, for a total transaction of $193,935.00. Following the completion of the acquisition, the director owned 50,907 shares in the company, valued at approximately $6,581,766.03. The trade was a 3.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 4.10% of the company’s stock.

Hawkins Stock Performance

Shares of HWKN stock opened at $146.61 on Tuesday. The firm has a 50 day moving average of $145.65 and a 200-day moving average of $154.49. The company has a market cap of $3.06 billion, a price-to-earnings ratio of 37.12, a price-to-earnings-growth ratio of 3.10 and a beta of 0.86. The company has a quick ratio of 1.46, a current ratio of 2.35 and a debt-to-equity ratio of 0.49. Hawkins, Inc. has a 52 week low of $98.30 and a 52 week high of $186.15.

Hawkins (NASDAQ:HWKN) last issued its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by ($0.03). The company had revenue of $244.08 million for the quarter, compared to the consensus estimate of $252.51 million. Hawkins had a return on equity of 16.85% and a net margin of 7.75%. On average, equities analysts forecast that Hawkins, Inc. will post 4 earnings per share for the current year.

Hawkins Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Investors of record on Friday, February 13th will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Friday, February 13th. Hawkins’s payout ratio is presently 19.24%.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. BWS Financial restated a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a report on Thursday, January 29th. Zacks Research raised Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. Finally, Weiss Ratings lowered Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Hawkins currently has a consensus rating of “Hold” and an average price target of $162.50.

Hawkins Company Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.